Ajanta Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajanta Pharma has submitted a compliance certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. Such filings are routine and typically relate to confirmation that the company's shares are held in dematerialised (demat) form through registered depositories such as NSDL or CDSL, along with details of the Registrar and Share Transfer Agent. No financial figures, share counts, or specific corporate actions were disclosed in the headline. The filing is purely a regulatory compliance update and not a business or operational announcement.
No material impact on shareholders or stock price. This is a standard regulatory filing confirming ongoing compliance with SEBI's depository norms and does not signal any change in business, ownership, or financial position.